(28 days)
Not Found
No
The 510(k) summary describes a standard PICC catheter with a mechanical valve. There is no mention of AI, ML, image processing, or any software-driven analytical capabilities. The performance studies focus on physical and mechanical properties of the catheter.
Yes.
This device provides venous access for "intravenous therapy," indicating its use in administering treatments.
No
Explanation: The device is a PICC (Peripherally Inserted Central Catheter) designed for venous access for intravenous therapy or blood sampling, not for diagnosing a condition.
No
The device description clearly outlines a physical catheter with specific material properties, dimensions, and a valve mechanism. The performance studies also focus on physical characteristics and mechanical testing of the hardware.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "peripheral access to the central venous system for intravenous therapy or blood sampling." This describes a device used in vivo (within the body) for delivering substances or collecting blood directly from the bloodstream.
- Device Description: The description details a catheter designed to be inserted into a blood vessel.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens in vitro (outside the body) to provide information about a physiological state, health, or disease. IVDs typically involve reagents, test strips, analyzers, or other components used to perform tests on samples like blood, urine, or tissue.
Therefore, this device is a medical device used for direct patient care, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The 4 Fr Single Lumcn Groshong® NXT PICC Catheter is designed for use in short term or long term intravenous therapy and any other therapies requiring long term central venous access (e.g. blood sampling). It is used for administration of hyperalimentation, chemotherapy and other I.V. fluids. The dual lumen feature permits simultaneous infusion of incompatible solutions and/or aspiration of blood samples. Refer to the appropriate drug labeling for indications, warnings, precautions, dosage and administration information.
The Groshong® NXT PICC provides short (less than 30 days) or long (greater than 30 days) term periphcral access to the central venous system for intravenous therapy or blood sampling.
Product codes
LJS
Device Description
The 4 Fr single lumen silicone Groshong® NXT PICC catheter is a 60 cm, trimmable catheter with depth markings. It has a closed, rounded, atraumatic, radiopaque distal tip with the 3-position, pressure-sensitive Groshong® valve.
It has a 2-piece connection with extension leg and lucr lock connector that is designed to be attached by the clinician after trimming the catheter tube to length. The connector has suture wings that are StatLockcompatible for stability.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
central venous system
Indicated Patient Age Range
Not Found
Intended User / Care Setting
clinician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing was performed using the Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters, dated 3/16/95 included assessments of Dimensions, Priming Volume, Flow Rate, Tensile, Elongation and Stiffness (Modulus) of Catheter Shaft, Tensile Extension Leg to Proximal (2-piece) Connector, Tensile Proximal connector to Distal Connector (2-picce), Tensile Catheter Shaft to Distal (2-piece) Connector, Catheter Tip Tensile, Assembly Leak (Leak at Hub), Catheter Assembly Burst, Catheter Collapse, Catheter Flexural Fatigue Tolerance (Cyclic Flexure).
Additional non-guidance testing performed: Creep (Static), Radiopacity, Valve Function, Kink Resistance, Stylet Drag, Flush-through Wire/fuer lock connector tensile, Flush-through Sytlet Luer Taper, Flush-through Stylet Air Leakage, Flush-through Stylet Ease of Assembly.
Performance data gathered in design verification testing demonstrated that the Groshong® NXT PICC is substantially equivalent to the predicate 5 Fr DL Groshong® PICC.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5970 Percutaneous, implanted, long-term intravascular catheter.
(a)
Identification. A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.(b)
Classification. Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.”
0
JAN 2 1 2004
4 Fr SL Groshong® NXT PICC 510(k)
Section 6
510(k) Summary of Safety and Effectiveness Information
4 Fr Single Lumen Groshong®NXT PICC Catheter
6.1 Submitter Information
Submitter Name: Bard Access Systems, Inc. (BAS) [Subsidiary of C. R. Bard, Inc.] Address: 5425 W. Amelia Earhart Drive Salt Lake City, UT 84116 Telephone Number: (801) 595-0700, Ext. 5439 Fax Number: (801) 595-4903 Contact Person: Peggy Keiffer Date of Preparation: 12/22/03
6.2 Device Name
| Device Name: | 4 Fr Single Lumen Groshong®NXT PICC Catheter |
|---|---|
| Trade Name: | 4 Fr Single Lumen Groshong®NXT PICC Catheter |
| Common/Usual Name: | Peripherally Inserted Central Catheter (PICC) |
| Classification Name: | Class II, 80 LJS - Long Term Intravascular Catheter |
| Classification Panel: | General Hospital |
6.3 Predicate Device(s):
Device Name: Trade Name: Common/Usual Name: Classification Name: Classification Panel: Premarket Notification:
5 Fr Dual Lumen Groshong® NXT PICC Catheter Groshong®NXT PICC Catheter Peripherally Inserted Central Catheter (PICC) Class II, 80 LJS - Long Term Intravascular Catheter General Hospital K023374
6.4 Device Description
The 4 Fr single lumen silicone Groshong® NXT PICC catheter is a 60 cm, trimmable catheter with depth markings. It has a closed, rounded, atraumatic, radiopaque distal tip with the 3-position, pressure-sensitive Groshong® valve.
It has a 2-piece connection with extension leg and lucr lock connector that is designed to be attached by the clinician after trimming the catheter tube to length. The connector has suture wings that are StatLockcompatible for stability.
000034
1
(4.5 Intended Use
The 4 Fr Single Lumcn Groshong® NXT PICC Catheter is designed for use in short term or long term intravenous therapy and any other therapies requiring long term central venous access (e.g. blood sampling). It is used for administration of hyperalimentation, chemotherapy and other I.V. fluids. The dual lumen feature permits simultaneous infusion of incompatible solutions and/or aspiration of blood samples. Refer to the appropriate drug labeling for indications, warnings, precautions, dosage and administration information.
This is the same intended use as previously cleared for the 5 Fr DL Groshong® NXT PICC Catheter, K023374.
6.5 Technological Characteristics Summary
New device is compared to Marketed Device
Yes.
Does the new device have the same indication statement?
Yes. However, there are minor modifications to the indication verbiage.
Does the new device have the same technological characteristics, e.g. design, material, etc.?
Not in all regards. The basic fundamental scientific technology of the catheter has not changed. I Iowever, the 4 Fr SL Groshong® NXT PICC has some minor differences from the predicate 5 Fr DL Groshong® NXT PICC.
Could the new characteristics affect safety or effectiveness?
Yes. The new characteristics could affect safety or effectiveness of the device.
Do the new characteristics raise new types of safety and effectiveness questions?
No. There are no new types of safety and effectiveness questions.
Do accepted scientific methods exist for assessing effects of the new characteristics?
Yes. Design performance is in compliance with the FDA's Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters, dated 3/16/ 95.
Are performance data available to assess effects of new characteristics?
Yes. Verification testing was performed according to protocols based on the above-referenced guidance document recommendations and additional standards.
Do performance data demonstrate equivalence?
00035
2
Yes. Performance data gathered in design verification testing demonstrated that the Groshong® NXT PICC is substantially equivalent to the predicate 5 Fr DL Groshong® PICC.
6.6 Nonclinical Performance Testing
Testing was performed using the Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters, dated 3/16/95 included assessments of:
-
- Dimensions
-
- Priming Volume
- Flow Rate 3)
- Tensile, Elongation and Stiffness (Modulus) of Catheter Shaft 4)
- Tensile Extension Leg to Proximal (2-piece) Connector 5)
- Tensile Proximal connector to Distal Connector (2-picce) 6)
-
- Tensile Catheter Shaft to Distal (2-piece) Connector
-
- Catheter Tip Tensile
-
- Assembly Leak (Leak at Hub)
-
- Catheter Assembly Burst
-
- Catheter Collapse
-
- Catheter Flexural Fatigue Tolerance (Cyclic Flexure)
Additional non-guidance testing performed:
-
- Creep (Static)
-
- Radiopacity
-
- Valve Function
-
- Kink Resistance
-
- Stylet Drag
-
- Flush-through Wire/fuer lock connector tensile
-
- Flush-through Sytlet Luer Taper
-
- Flush-through Stylet Air Leakage
-
- Flush-through Stylet Ease of Assembly
6.8 Conclusion
The 4 Fr SL Groshong® NXT PICC is substantially to the predicate device 5 Fr DL Groshong® NXT PICC, K023374, cleared December 18, 2002.
000036
3
Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle or bird-like figure, composed of three curved lines that suggest the head, body, and tail feathers. The logo is rendered in black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 2 1 2004
Ms. Peggy Keiffer Senior Regulatory Affairs Manager Bard Access Systems, Incorporated 5425 West Amelia Earhart Drive Salt Lake City, Utah 84116
Re: K034020
Trade/Device Name: 4 Fr Single Lumen Groshong® NXT PICC Catheter Regulation Number: 21 CFR 880.5970 Regulation Name: Percutaneous, Implanted Long-tem Intravascular Catheter Regulatory Class: II Product Code: LJS Dated: December 22, 2003 Received: December 24, 2003
Dear Ms. Keiffer:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Ms. Keiffer
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has madc a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4618. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Cave
Chiu Lin, Ph., D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Section 1.2
4 Fr Single Lumen Groshong® NXT PICC Catheter 510(k)
INDICATION(S) FOR USE STATEMENT*
I state in my capacity as Senior Regulatory Affairs Manager of Bard Access Systems, that this notification [510(k)] for the following devices, 4 Fr Single Lumen Groshong® NXT PICC Catheter, is indicated for the following:
The Groshong® NXT PICC provides short (less than 30 days) or long (greater than 30 days) term periphcral access to the central venous system for intravenous therapy or blood sampling.
Buzzy Kriffo
Typed Name:
Peggy Keiffer Senior Regulatory Affairs Manager
Date:
12.27.03
*Suggested language and format to meet the requirements of sections 513(i) of the Federal Food, Drug, and Cosmetic Act, as amended, and sections 807.92(a)(5) and 801.4 of the Code of Federal Regulations, Title 21.
Concurrence of Office of Device Evaluation
510(k) Number
iRo3402D
Prescription Use
Over-The-Counter Use
Viola Hubbard, catering service Chief
eneral Hospital, nesthesic
OR
510(k) Number: K034020
COOOOOO